FDA readies for cough/cold meeting
This article was originally published in The Tan Sheet
Executive Summary
An FDA spokeswoman said Sept. 26 the agenda for the Oct. 2 meeting on OTC cough/cold products has yet to be finalized but approximately 28 parties are scheduled to make presentations. Since announcing the meeting Aug. 25, FDA has received comments from two parties, including Wayne Snodgrass, one of the petitioners whose filing led to FDA's review of pediatric cough/cold safety (1"The Tan Sheet" Oct. 22, 2007, p. 3)